are expecting [60:100 kg: 1,000 mg SubQ: 125 mg once weekly. Note: Administer without an IV loading dose. If transitioning from IV therapy to SubQ therapy, administer the first SubQ dose instead of the next scheduled IV dose. Rheumatoid arthritis (RA): IV: Dosing is according to body weight. Following the initial IV infusion (using the weight-based dosing), repeat IV infusion (using the same weight-based dosing) at 2 weeks and 4 weeks after the initial infusion, and every 4 weeks thereafter.] Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Abatacept Rating 29 User Reviews 6.6 /10 29 User Reviews 6.6 Rate it! Drug Class Antirheumatics Selective immunosuppressants Related Drugs antirheumatics methotrexate , hydroxychloroquine , Plaquenil , Humira , sulfasalazine , azathioprine selective immunosuppressants leflunomide , CellCept , mycophenolate mofetil , Arava , Tecfidera , Orencia Rheumatoid Arthritis Humira , hydroxychloroquine , Plaquenil , sulfasalazine , leflunomide , Enbrel , Remicade , Rituxan , More... Juvenile Idiopathic Arthritis Humira , methotrexate , Enbrel , adalimumab , Orencia , Actemra , etanercept , Rasuvo , More... Psoriatic Arthritis prednisone , Humira , triamcinolone , methotrexate , dexamethasone , Enbrel , Decadron , Remicade , More... more healthy
appears to be Abatacept agency
EmoticonEmoticon